Wilma™ is revolutionizing ABA with AI-Driven Data Collection for Better Care and Less Burnout. DIABLO, Calif., May 13, 2025 /PRNewswire/ -- Wilma™, the industry-leading AI-powered practice ...

announces that it will present preclinical data on its next generation autotaxin inhibitor, IOA-289, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting taking place on November 10 ...

The data presented at ASCO will show that IOA-244 has potentially best-in-class tolerability and impressive overall survival in refractory uveal melanoma patients. We are looking forward to ...